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Summary 
Nanoscale science, engineering, and technology—commonly referred to collectively as 
nanotechnology—is believed by many to offer extraordinary economic and societal benefits. 
Congress has demonstrated continuing support for nanotechnology and has directed its attention 
particularly to three topics that may affect the realization of this hoped for potential: federal 
research and development (R&D) in nanotechnology; U.S. competitiveness in the field; and 
environmental, health, and safety (EHS) concerns. This report provides an overview of these 
topics and two others: nanomanufacturing and public understanding of and attitudes toward 
nanotechnology. 
The development of this emerging field has been fostered by significant and sustained public 
investments in nanotechnology R&D. Nanotechnology R&D is directed toward the understanding 
and control of matter at dimensions of roughly 1 to 100 nanometers. At this size, the properties of 
matter can differ in fundamental and potentially useful ways from the properties both of individual 
atoms and molecules, on the one hand, and of bulk matter, on the other. Since the launch of the 
National Nanotechnology Initiative (NNI) in 2000, Congress appropriated approximately $21.8 
billion for nanotechnology R&D through FY2016. President Obama has requested $1.4 billion in 
NNI funding for FY2017, up $8.7 million (0.6%) from the FY2016 level and down $469.4 million 
(24.5%) from its regular appropriation peak of $1.913 billion in FY2010. 
While more than 60 nations established similar programs after the launch of the NNI, it appears 
that several have moved away from centralized, coordinated nanotechnology-focused programs 
(e.g., the United Kingdom, Japan, Russia), some in favor of market- or application-oriented topic 
areas (e.g., health care technologies). By one estimate, in 2012, total annual global public R&D 
investment was $7.5 billion, down from $8.3 billion in 2010; corporate nanotechnology R&D 
spending in 2012 was an estimated $10 billion. Data on economic outputs used to assess 
competitiveness in mature technologies and industries, such as revenues and market share, are not 
broadly available for assessing nanotechnology. As an alternative, data on inputs (e.g., R&D 
expenditures) and non-financial outputs (e.g., scientific papers or patents) may provide insight 
into the current U.S. position and serve as bellwethers of future competitiveness. By these 
criteria, the United States appears to be the overall global leader in nanotechnology, though some 
believe the U.S. lead may not be as large as it was for previous emerging technologies. In recent 
years, China and the countries of the European Union have surpassed the United States in the 
publication of nanotechnology papers. 
Some research has raised concerns about the safety of nanoscale materials. There is general 
agreement that more information on EHS implications is needed to protect the public and the 
environment; to assess and manage risks; and to create a regulatory environment that fosters 
prudent investment in nanotechnology-related innovation. Nanomanufacturing—the bridge 
between nanoscience and nanotechnology products—may require the development of new 
technologies, tools, instruments, measurement science, and standards to enable safe, effective, 
and affordable commercial-scale production of nanotechnology products. Public understanding 
and attitudes may also affect the environment for R&D, regulation, and market acceptance of 
products incorporating nanotechnology. 
In 2003, Congress enacted the 21st Century Nanotechnology Research and Development Act (P.L. 
108-153) providing a legislative foundation for some of the activities of the NNI, addressing 
concerns, establishing programs, assigning agency responsibilities, and setting authorization 
levels. In the 114th Congress, Subtitle B of H.R. 1898 (America Competes Reauthorization Act of 
2015) would reauthorize the NNI. Previous efforts to enact comprehensive NNI reauthorization 
legislation in the 110th Congress, 111th Congress, and 113th Congress were unsuccessful. 
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Overview 
Congress continues to demonstrate interest in and support for nanotechnology due to what many 
believe is its extraordinary potential for delivering economic growth, high-wage jobs, and other 
societal benefits to the nation. To date, Congress has directed its attention particularly to three 
topics that may affect the United States’ realization of this hoped for potential: federal research 
and development (R&D) investments under the National Nanotechnology Initiative (NNI); U.S. 
international competitiveness in nanotechnology; and environmental, health, and safety (EHS) 
concerns. This report provides a brief overview of these topics and two other subjects of interest 
to Congress: nanomanufacturing and public attitudes toward, and understanding of, 
nanotechnology.1 
Nanotechnology R&D is directed toward the understanding and control of matter at dimensions 
of roughly 1 to 100 nanometers. At this size, the physical, chemical, and biological properties of 
materials can differ in fundamental and potentially useful ways from both the properties of 
individual atoms and molecules, on the one hand, and bulk matter, on the other hand. 
In 2000, President Clinton launched the NNI to coordinate federal R&D efforts and promote U.S. 
competitiveness in nanotechnology. Congress first funded the NNI in FY2001 and provided 
increased regular appropriations for nanotechnology R&D for each year through FY2010.2 From 
FY2010 to FY2016, however, overall NNI funding has declined by $478 million (25.0%); during 
the same period, overall federal R&D funding fell by less than one percent. President Obama’s 
proposed funding of $1.443 billion for nanotechnology R&D for FY2016 is essentially the same 
as the FY2015 level.  
In 2003, Congress enacted the 21st Century Nanotechnology Research and Development Act (P.L. 
108-153). The act provided a statutory foundation for the NNI, established programs, assigned 
agency responsibilities, and authorized agency funding levels for FY2005 through FY2008. 
Though no funding has been explicitly authorized for the NNI beyond FY2008, Congress has 
continued to appropriate funds to agencies for nanotechnology research, and the executive branch 
continues to operate and report on the NNI, as coordinated by the Nanoscale Science, 
Engineering, and Technology (NSET) subcommittee of the National Science and Technology 
Council (NSTC). 
Federal R&D investments are focused on advancing understanding of fundamental nanoscale 
phenomena and on developing nanomaterials, nanoscale devices and systems, instrumentation, 
standards, measurement science, and the tools and processes needed for nanomanufacturing. NNI 
appropriations also fund the construction and operation of major research facilities and the 
acquisition of instrumentation. The NNI also supports research directed at identifying and 
managing potential environmental, health, and safety impacts of nanotechnology, as well as its 
ethical, legal, and societal implications. 
Most current applications of nanotechnology are evolutionary in nature, offering incremental 
improvements to existing products and generally modest economic and societal benefits. For 
                                                 
1 For additional information on these issues, see CRS Report RL34401, The National Nanotechnology Initiative: 
Overview, Reauthorization, and Appropriations Issues; CRS Report RL34493, Nanotechnology and U.S. 
Competitiveness: Issues and Options; and CRS Report RL34614, Nanotechnology and Environmental, Health, and 
Safety: Issues for Consideration, all by John F. Sargent; and CRS Report RL34332, Engineered Nanoscale Materials 
and Derivative Products: Regulatory Challenges, by Linda-Jo Schierow. 
2 Funding under the American Recovery and Reinvestment Act of 2009 (P.L. 111-5) provided, among other things, a 
one-year boost in NNI funding, bringing total funding to $2.213 billion in FY2009. 
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example, nanotechnology is being used in microchips to improve speed and energy use while 
reducing size and weight; in display screens to improve picture quality, provide wider viewing 
angles, and longer product lives; in automobile bumpers, cargo beds, and step-assists to reduce 
weight, increase resistance to dents and scratches, and eliminate rust; in clothes to increase 
resistance to staining, wrinkling, and bacterial growth and to provide lighter-weight body armor; 
and in sporting goods, such as baseball bats and golf clubs, to improve performance.3 
In the longer term, proponents of nanotechnology believe it may deliver revolutionary advances 
with profound economic and societal implications. The applications they discuss involve various 
degrees of speculation and varying time-frames. The examples below suggest a few of the areas 
where revolutionary advances may emerge, and for which early R&D efforts may provide 
insights into how such advances may be achieved. As yet, however, most of these examples are at 
an early stage of development. 
 Detection and treatment technologies for cancer and other diseases. Current 
nanotechnology disease detection efforts include the development of sensors that 
can identify biomarkers—such as altered genes,4 receptor proteins that are 
indicative of newly-developing blood vessels associated with early tumor 
development,5 and prostate specific antigen (PSA)6—that may provide an early 
indicator of cancer.7 One approach uses carbon nanotubes and nanowires to 
identify the unique molecular signals of cancer biomarkers. Another approach 
uses nanoscale cantilevers—resembling a row of diving boards—treated with 
molecules that bind only with cancer biomarkers. When these molecules bind, the 
additional weight bends the cantilevers indicating the presence and concentration 
of these biomarkers. Nanotechnology holds promise for showing the presence, 
location, and/or contours of cancer, cardiovascular disease, or neurological 
disease. Current R&D efforts employ metallic, magnetic, and polymeric 
nanoparticles with strong imaging characteristics attached to an antibody or other 
agent that binds selectively with targeted cells. The imaging results can be used 
to guide surgical procedures and to monitor the effectiveness of non-surgical 
therapies in killing the disease or slowing its growth. Nanotechnology may also 
offer new cancer treatment approaches. For example, nanoshells with a core of 
silica and an outer metallic shell can be engineered to concentrate at cancer 
lesion sites. Once at the sites, a harmless energy source (such as near-infrared 
light) can be used to cause the nanoshells to heat, killing the cancer cells they are 
attached to.8 Another treatment approach targets delivery of tiny amounts of a 
chemotherapy drug to cancer cells. In this approach the drug is encapsulated 
within a nanoshell that is engineered to bind with an antigen on the cancer cell. 
                                                 
3 National Nanotechnology Initiative website, Benefits and Applications, http://www.nano.gov/you/nanotechnology-
benefits. 
4 See, for example, National Institutes of Health, U.S. National Library of Medicine website, “Multiplexed 
Fluorescence Imaging of Tumor Biomarkers in Gene Expression and Protein Levels for Personalized and Predictive 
Medicine,” Mark Q. Smith et al., March 12, 2013, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594694/ 
5 National Cancer Institute website, Nanotechnology in Clinical Trials, http://nano.cancer.gov/learn/now/clinical-
trials.asp. 
6 Ibid. 
7 National Institutes of Health, U.S. National Library of Medicine website, “Biomarkers in cancer screening, research 
and detection: present and future: a review,” S. Kumar et al., September-October 2006, http://www.ncbi.nlm.nih.gov/
pubmed/16966157. 
8 National Cancer Institute website, Nanoshells, http://nano.cancer.gov/learn/understanding/nanotech_nanoshells.asp. 
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Once bound, the nanoshell dissolves, releasing the chemotherapy drug, killing 
the cancer cell. Such a targeted delivery approach could reduce the amount of 
chemotherapy drug needed to kill the cancer cells, reducing the side effects of 
chemotherapy.9 A more recent advance may enable a nanoparticle to carry three 
or more different drugs and release them “in response to three distinct triggering 
mechanisms.”10 
 Renewable power. Nanoscale semiconductor catalysts and additives show 
promise for improving the production of hydrogen from water using sunlight. 
The optical properties of these nanoscale catalysts allow the process to use a 
wider spectrum of sunlight. Similarly, nanostructured photovoltaic devices (e.g., 
solar panels) may improve the efficiency of converting sunlight into electricity by 
using a wider spectrum of sunlight. Improved hydrogen storage, a key challenge 
in fuel cell applications, may be achieved by tapping the chemical properties and 
large surface area of certain nanostructured materials. In addition, carbon 
nanotube fibers have the potential for reducing energy transmission losses from 
approximately 7% (using copper wires) to 6% (using carbon nanotube fibers), an 
equivalent annual energy savings in the United States of 24 million barrels of 
oil.11 
 Water treatment. Nanotechnology approaches—such as nanosorbents, 
nanocatalysts, bioactive nanoparticles, nanostructured catalytic membranes, and 
nanoparticle enhanced filtration—may enable improved water quality in both 
large-scale water treatment plants and point-of-use systems.12 Nanotechnology 
water desalination and filtration systems may offer affordable, scalable, and 
portable water filtration systems. Filters employing nanoscale pores work by 
allowing water molecules to pass through, but prevent larger molecules, such as 
salt ions and other impurities (e.g., bacteria, viruses, heavy metals, and organic 
material), from doing so. Some nanoscale filtration systems also employ a matrix 
of polymers and nanoparticles that serve to attract water molecules to the filter 
and to repel contaminants.13  
 High-density memory devices, faster data access. A variety of nanotechnology 
applications may hold the potential for improving the density of memory storage 
and accelerate access speed to stored data.14 
                                                 
9 National Cancer Institute, http://nano.cancer.gov/resource_center/tech_backgrounder.asp. Nanotech News, 
Nanoparticles Enhance Combination Chemotherapy and Radiation Therapy, April 2012, http://nano.cancer.gov/action/
news/2012/apr/nanotech_news_2012-4-2f.asp; Nanotech News, First-Of-Its-Kind Self-Assembled Nanoparticle for 
Targeted and Triggered Thermo-Chemotherapy, December 2012, http://nano.cancer.gov/action/news/2012/dec/
nanotech_news_2012-12-13b.asp; and National Cancer Institute, NCI Alliance for Nanotechnology in Cancer, 2011 
NCI Alliance Annual Bulletin, Joe Alper, Nanoparticles Deliver Drug Cocktails to Tumor, 2011. 
10 Massachusetts Institute of Technology, MIT News, “Targeting Cancer with a Triple Threat,” April 15, 2014, 
https://newsoffice.mit.edu/2014/nanoparticles-can-deliver-three-cancer-drugs-at-once-0415. 
11 Nanoscale Science, Engineering, and Technology Subcommittee, National Science and Technology Council, The 
White House, Nanoscience Research for Energy Needs, December 2004. 
12 Anita Street, Richard Sustich, Jeremiah Duncan, Nora Savage, eds., Nanotechnology Applications for Clean Water: 
Solutions for Improving Water Quality, 2nd ed. (Elsevier, 2014). 
13 Abraham, M., “Today’s Seawater is Tomorrow’s Drinking Water,” University of California at Los Angeles, 
November 6, 2006; and NNI website, Benefits and Applications, http://www.nano.gov/you/nanotechnology-benefits. 
14 EurekAlert!, American Association for the Advancement of Science, “Memory Breakthrough Could Bring Faster 
Computing, Smaller Memory Devices and Lower Power Consumption,” http://www.eurekalert.org/pub_releases/2013-
08/thuo-mbc081413.php; and IBM Research, Silicon Integrated Nanophotonics, http://researcher.ibm.com/researcher/
(continued...) 
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 Higher crop yields and improved nutrition. Higher crop yield might be 
achieved using nanoscale sensors that detect the presence of a virus or disease-
infecting particle. Early, location-specific detection may allow for rapid and 
targeted treatment of affected areas, increasing yield by preventing losses.15 
Nanotechnology also offers the potential for improved nutrition. Some 
companies are exploring the development of nanocapsules that release nutrients 
targeted at specific parts of the body at specific times.16 
 Self-healing materials. Nanotechnology may offer approaches that enable 
materials to “self-heal” by incorporating, for example, nanocontainers of a repair 
substance (e.g., an epoxy) throughout the material. When a crack or corrosion 
reaches a nanocontainer, the nanocontainer could be designed to open and release 
its repair material to fill the gap and seal the crack.17 
 Toxin and pathogen sensors. Microfluidic and nanocantilever sensors 
(discussed earlier) may be engineered to detect specific pathogens (e.g., bacteria, 
virus) or toxins (e.g., sarin gas, hydrogen cyanide) by detecting their unique 
molecular signals or through selective binding with an engineered nanoparticle.18 
 Environmental remediation. The high surface-to-volume ratio, high reactivity, 
and small size of some nanoscale particles (e.g., nanoscale iron) may offer more 
effective and less costly solutions to environmental contamination. By injecting 
engineered nanoparticles into the ground, these characteristics can be employed 
to enable the particles to move more easily through a contaminated site and bond 
more readily with targeted contaminants.19 
Nanotechnology is also expected by some to make substantial contributions to federal missions 
such as national defense, homeland security, and space exploration and commercialization. 
U.S. private-sector nanotechnology R&D funding (corporate and venture capital) is estimated to 
be more than twice the amount of U.S. public funding.20 In general, the private sector’s efforts 
focus on translating fundamental knowledge and prototypes into commercial products; 
developing new applications incorporating nanoscale materials; and developing technologies, 
                                                                
(...continued) 
view_project.php?id=2757. 
15 Nanoscale Science and Engineering for Agriculture and Food Systems, draft report on the National Planning 
Workshop, submitted to the Cooperative State Research, Education, and Extension Service of the U.S. Department of 
Agriculture, July 2003. 
16 Kole, Chittaranjan, Kole, Phullara et al., “Nanobiotechnology Can Boost Crop Production and Quality: First 
Evidence from Increased Plant Biomass, Fruit Yield and Phytomedicine Content in Bitter Melon,” BMC 
Biotechnology, PubMed, April 26, 2013, http://www.ncbi.nlm.nih.gov/pubmed/23622112?dopt=Abstract&holding=
f1000,f1000m,isrctn; and Wolfe, Josh. “Safer and Guilt-Free Nano Foods,” Forbes.com, August 10, 2005. 
17 Antoni P. Tomsia, Maximilien E. Launey, and Janice S. Lee et al., “Nanotechnology Approaches for Better Dental 
Implants,” International Journal of Oral Maxillofac Implants, 2011, pp. 25-49.White, Scott R. and Geubelle, Philippe 
H., “Self-Healing Materials: Get Ready for Repair-and-Go,” Nature Nanotechnology, Vol. 5, pp. 247-248, 2010, 
http://www.nature.com/nnano/journal/v5/n4/abs/nnano.2010.66.html; Berger, Michael. “Nanomaterial Heal Thyself,” 
Nanowerk Spotlight, June 13, 2007, http://www.nanowerk.com/spotlight/spotid=2067.php. 
18 “Nanotechnology for Sensors and Sensors for Nanotechnology,” Nanotechnology Signature Initiative, National 
Science and Technology Council, July 9, 2012, http://www.nano.gov/sites/default/files/pub_resource/
sensors_nsi_2012_07_09_final_for_web.pdf. 
19 EPA website, http://epa.gov/ncer/nano/research/nano_remediation.html. 
20 Hilary Flynn, David Hwang, and Michael Holman, Nanotechnology Update: Corporations Up Their Spending as 
Revenues for Nano-Enabled Products Increase, Lux Research, Inc., February 2014. 
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methods, and systems for commercial-scale manufacturing. Many other nations and firms around 
the world are also making substantial investments in nanotechnology.  
With so much potentially at stake, some Members of Congress have expressed concerns about the 
U.S. competitive position in nanotechnology R&D and U.S. success in translating R&D results to 
commercial products. These concerns have led to an increased focus on barriers to 
commercialization efforts, including the readiness of technologies, systems, and processes for 
large-scale nanotechnology manufacturing; potential environmental, health, and safety (EHS) 
effects of nanoscale materials; public understanding and attitudes toward nanotechnology; and 
other related issues.  
This report provides an overview of the NNI, federal R&D investments in nanotechnology, U.S. 
competitiveness in nanotechnology, and EHS-related issues. 
The National Nanotechnology Initiative 
President Clinton launched the National Nanotechnology Initiative in 2000, establishing a multi-
agency program21 to coordinate and expand federal efforts to advance the state of nanoscale 
science, engineering, and technology, and to position the United States to lead the world in 
nanotechnology research, development, and commercialization. In FY2016, the NNI includes 11 
federal departments and independent agencies and commissions with budgets dedicated to 
nanotechnology R&D, as well as 9 other federal departments and independent agencies and 
commissions with responsibilities for health, safety, and environmental regulation; trade; 
education; training; intellectual property; international relations; and other areas that might affect 
nanotechnology.22 The Environmental Protection Agency and the Food and Drug Administration 
both conduct nanotechnology R&D and have regulatory responsibilities. 
Congress has played a central role in the NNI, providing appropriations for the conduct of 
nanotechnology R&D, establishing programs, and creating a legislative foundation for some of 
the activities of the NNI through enactment of the 21st Century Nanotechnology Research and 
Development Act of 2003. The act authorized appropriations for FY2005 through FY2008 for 
NNI activities at five agencies: the National Science Foundation (NSF), Department of Energy 
(DOE), National Aeronautics and Space Administration (NASA), Department of Commerce 
(DOC) National Institute of Standards and Technology (NIST), and Environmental Protection 
Agency (EPA).  
Congress has continued its active engagement in the NNI through hearings, proposed authorizing 
legislation, and annual appropriations. While many provisions of the 21st Century 
Nanotechnology Research and Development Act have no sunset provision, FY2008 was the last 
year for which it authorized appropriations.  
Legislation to amend and reauthorize the act was introduced in the 114th Congress, 113th 
Congress, 111th Congress, and 110th Congress. No comprehensive reauthorization legislation was 
introduced in 112th Congress. In the 114th Congress, Subtitle B of H.R. 1898, the America 
COMPETES Reauthorization Act of 2015, would reauthorize the National Nanotechnology 
                                                 
21 The original six NNI agencies were the NSF, DOD, DOE, NIST, NASA, and NIH. 
22 Previously the NNI counted more than 20 participating agencies, however departments with multiple participating 
agencies are now counted as a single participant. For example, four agencies of the Department of Commerce 
participate in the NSET subcommittee—the National Institute of Standards and Technology, Economic Development 
Administration, Bureau of Industry and Security, and U.S. Patent and Trademark Office—but are only counted as a 
single participating department. 
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Initiative. In the 113th Congress, bills were introduced in the House and Senate that sought to 
amend the 21st Century Nanotechnology Research and Development Act. In the House bill, the 
National Nanotechnology Initiative Amendments Act of 2014 was incorporated as part of H.R. 
4159, the America COMPETES Reauthorization Act of 2014, which was referred to two 
committees and multiple subcommittees. No further action was taken on the bill. In the Senate, 
the National Nanotechnology Initiative Amendments Act of 2014 was incorporated as part of S. 
2757, the America COMPETES Reauthorization Act of 2014. S. 2757 was referred to the Senate 
Committee on Commerce, Science, and Transportation and no further action was taken. During 
markup of the Frontiers in Innovation, Research, Science, and Technology Act of 2014 (H.R. 
4186) by the House Committee on Science, Space, and Technology, an amendment to add a title 
reauthorizing the NNI was defeated. Earlier efforts to reauthorize the 21st Century 
Nanotechnology Research and Development Act are discussed in CRS Report RL34401, The 
National Nanotechnology Initiative: Overview, Reauthorization, and Appropriations Issues, by 
John F. Sargent Jr. 
Structure 
The NNI is coordinated within the White House through the National Science and Technology 
Council’s NSET subcommittee. The NSET subcommittee is comprised of representatives from 20 
federal departments and agencies, the Office of Science and Technology Policy (OSTP), and the 
Office of Management and Budget. (A list of NSET subcommittee member agencies is provided 
in the Appendix.) The NSET subcommittee has two working groups: National Environmental 
and Health Implications (NEHI) Working Group; and Nanomanufacturing, Industry Liaison, and 
Innovation (NILI) Working Group. Two previous working groups—Global Issues in 
Nanotechnology (GIN) Working Group and Nanotechnology Public Engagement and 
Communications (NPEC) Working Group—were eliminated.23 Based on a 2010 recommendation 
by the President’s Council of Advisors on Science and Technology (PCAST), the NSET 
subcommittee has designated coordinators for four broad areas—global issues; standards 
development; environmental, health, and safety research; and education, engagement, and societal 
dimensions—to “track developments, lead in organizing activities, report periodically to the 
NSET subcommittee, and serve as central points of contact for NNI information in the 
corresponding areas.”24 The National Nanotechnology Coordination Office (NNCO) provides 
administrative and technical support to the NSET subcommittee. 
Funding 
This section provides information on NNI funding by agency and by program component area 
(PCA). 
Funding by Agency 
Funding for the NNI is provided through appropriations to each of the NNI-participating 
agencies. The NNI has no centralized funding. Overall NNI funding is calculated by aggregating 
the nanotechnology-related expenditures of each agency. Funding remains concentrated in the 
original six NNI agencies (see footnote 21), which account for 94.2% of NNI funding in FY2016.  
                                                 
23 The NSET subcommittee “periodically reviews the need for existing or new working groups in terms of focus, 
intended participation, and scope.” NSET, NSTC, National Nanotechnology Initiative Strategic Plan, February 2014, 
p. 52, http://nano.gov/sites/default/files/pub_resource/2014_nni_strategic_plan.pdf. 
24 NSET, NSTC, National Nanotechnology Initiative Strategic Plan, February 2014, pp. 53-54. 
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For FY2016, Congress appropriated an estimated $1.435 billion for nanotechnology R&D, down 
$61.6 million (4.1%) in current dollars from the FY2015 level of $1.913 billion. The FY2016 
appropriation is also down $478.1 million (25.0%) from peak regular appropriation funding in 
FY2010 (see Figure 1). The decrease is 32.2% in inflation-adjusted dollars (see Figure 2).25 In 
total, Congress has appropriated approximately $22.3 billion for the NNI from FY2001 to 
FY2016. President Obama has requested $1.443 billion for nanotechnology R&D in FY2016, 
essentially the same as the estimated total appropriated for FY2015. NNI funding by agency is 
detailed in Table 1. 
Figure 1. Total NNI Funding in Current Dollars, FY2001-FY2017 (Request) 
 
Source: CRS analysis of NNI data. 
Note: ARRA = American Recovery and Reinvestment Act of 2009. 
Figure 2. Total NNI Funding in Constant FY2016 Dollars, FY2001-FY2017 (Request) 
 
Source: CRS analysis of NNI data. 
Notes: ARRA = American Recovery and Reinvestment Act of 2009. Dollars adjusted using GDP (Chained) Price 
Index data obtained from Office of Management and Budget, Budget of the United States Government, Fiscal Year 
2017, Historical Tables, Table 10.1, adjusted to FY2016 dollars. 
                                                 
25 Total NNI funding was higher in FY2009 when regular appropriations and American Recovery and Reinvestment 
Act (ARRA) funding are counted. 
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Table 1. NNI Funding by Agency, FY2001-FY2017 
(in millions of current dollars) 
Agency 
FY2001 
Actual 
FY2002 
Actual 
FY2003 
Actual 
FY2004 
Actual 
FY2005 
Actual 
FY2006 
Actual 
FY2007 
Actual 
FY2008 
Actual 
FY2009 
Actual 
FY2009 
ARRA 
National Science Foundation 150 204 221 256 335 360 389 409 409 101 
National Institutes of Healtha 40 59 78 106 165 192 215 305 343 73 
Department of Energyb 88 89 134 202 208 231 236 245 333 293 
Department of Defensec 125 224 220 291 352 424 450 460 459  
NIST 33 77 64 77 79 78 88 86 93 43 
Environmental Protection Agency 5 6 5 5 7 5 8 12 12  
Food and Drug Administration         7  
NASA 22 35 36 47 45 50 20 17 14  
Dept. of Homeland Security  2 1 1 1 2 2 3 9  
Other Agencies 1 1 2 4 8 11 17 18 24  
TOTALd 464 697 760 989 1,200 1,351 1,425 1,554 1,702 511 
 
Agency 
FY2010 
Actual 
FY2011 
Actual 
FY2012 
Actual 
FY 2013 
Actual 
FY2014 
Actual 
FY2015 
Actual 
FY2016 
Est. 
FY2017 
Request 
National Science Foundation 429 485 466 421 465 490 415 415 
National Institutes of Healtha 457 409 456 459 410 364 382 382 
Department of Energyb 374 346 314 314 309 313 330 362 
Department of Defensec 440 425 426 170 190 143 134 131 
NIST 115 96 95 91 98 84 80 82 
Environmental Protection Agency 18 17 18 15 16 15 14 15 
Food and Drug Administration 7 10 14 16 9 11 12 11 
NASA 20 17 19 16 22 14 11 6 
Dept. of Homeland Security 22 9 19 14 25 28 21 2 
Other Agencies 33 33 31 34 31 35 36 38 
TOTALd 1,913 1,847 1,857 1,550 1,574 1,496 1,435 1,443 
Source: NNI website, http://www.nano.gov/. Figures for FY2012 and FY2017 from annual NNI budget 
supplements, National Science and Technology Council, Executive Office of the President (EOP). 
a. According to NIH, the agency has adopted the Research, Condition, and Disease Categorization (RCDC) 
system to provide more consistent and transparent information to the public about NIH research. The shift 
to the RCDC process of categorization changes the way individual research projects are assigned to 
categories. This change will result in some differences in total dollar amounts between the 2008 reports and 
those issued in previous years. Any difference, whether an increase or decrease in funding levels, does not 
necessarily reflect a change in the amount of money the NIH received from Congress or a change in the 
actual content of the NIH research portfolio. For more information, please go to: http://report.nih.gov/rcdc/
reasons/default.aspx. Funding for other Department of Health and Human Services agencies (i.e., the Food 
and Drug Administration and National Institute for Occupational Safety and Health) is included in the figure 
for “Other Agencies.” 
b. According to NSTC, funding levels for DOE include the combined budgets of the Office of Science, the 
Office of Energy Efficiency and Renewable Energy, the Office of Fossil Energy, and the Advanced Research 
Projects Agency for Energy.  
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c. According to NSTC, the Department of Defense actual figures for FY2006 and beyond include 
congressionally directed funding. The extent to which such funding is included or not included in reporting 
of funding in earlier fiscal years is uncertain. 
d. Numbers may not add to total due to rounding of agency budget figures. 
Funding by Program Component Area 
The 21st Century Nanotechnology R&D Act of 2003 called for the NSET Subcommittee to 
develop categories of investment called Program Component Areas (PCA) to provide a means by 
which Congress and the executive branch can be informed of and direct the relative investments 
in these areas. The PCAs cut across the needs and interests of individual agencies and contribute 
to the achievement of one or more of the NNI’s goals.  
The 2004 NNI Strategic Plan identified seven PCAs. The 2007 NNI Strategic Plan split the 
seventh PCA, Societal Dimensions, into two PCAs: Environment, Health, and Safety; and 
Education and Societal Dimensions. In 2014, the NSET Subcommittee revised its taxonomy for 
PCAs “to accommodate the maturation of the Initiative, the enhanced emphasis on applications, 
and the greater participation by agencies and communities that are not focused primarily on 
R&D.”26 The revision reduces the number of PCAs from eight to five.27  
Table 2 provides a funding breakout using the new PCA structure for FY2013-FY2017 (request). 
Table 2. Funding by Program Component Area, FY2013-FY2017 (Request) 
(in millions of current dollars) 
PCA 
FY2013 
Actual 
FY2014 
Actual 
FY2015 
Actual 
FY2016 
Estimated 
FY2017 
Request 
Nanotechnology Signature Initiatives $ 279.9 $272.8 $283.6 171.6 158.3 
- Nanotechnology for Solar Energy Collection and Conversion 73.6 73.2 66.7 0 0 
- Sustainable Nanomanufacturing 34.7 47.2 44.9 36.7 37.4 
- Nanoelectronics for 2020 and Beyond 87.3 78.6 95.5 81.8 69.8 
- Nanotechnology Knowledge Infrastructure 7.5 15.9 27.9 23.2 22.1 
- Nanotechnology for Sensors and Sensors for Nanotechnology 76.8 58.0 48.6 29.8 29.0 
Foundational Research 581.3 548.9 521.6 572.8 601.0 
Nanotechnology-enabled Applications, Devices, and 
Systems 
361.4 418.8 374.5 365.0 349.5 
Research Infrastructure and Instrumentation 212.5 231.6 219.9 231.2 234.6 
Environment, Health, and Safety 115.1 102.1 96.7 94.1 100.1 
Total $1,550.2 
1,550.2 
$1,574.3 $1,496.3 $1,434.7 1,443.4 
Source: NSET Subcommittee, NSTC, EOP, Supplements to the President’s Budget, FY2014-FY2017.  
Notes: Totals may differ from the sum of the components due to rounding. 
                                                 
26 NSET Subcommittee, NSTC, EOP, The National Nanotechnology Initiative Strategic Plan, February 2014, 
http://nano.gov/sites/default/files/pub_resource/2014_nni_strategic_plan.pdf. 
27 The five PCAs are: Nanotechnology Signature Initiatives; Foundational Research; Nanotechnology-enabled 
Applications, Devices, and Systems; Nanotechnology-enabled Applications, Devices, and Systems; and Research 
Infrastructure and Instrumentation. A description of the new PCAs and a chronology of NNI funding by PCA since 
FY2001 is available in CRS Report RL34401, The National Nanotechnology Initiative: Overview, Reauthorization, and 
Appropriations Issues, by John F. Sargent Jr. 
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Selected Issues 
The remainder of this report discusses four issues of congressional interest with respect to 
nanotechnology: U.S. competitiveness; environmental, health, and safety implications; 
nanomanufacturing; and public attitudes and understanding. 
U.S. Competitiveness 
Nanotechnology is largely still in its infancy. Accordingly, measures such as revenues, market 
share, and global trade statistics—which are often used to assess and track U.S. competitiveness 
in more mature technologies and industries—are generally not available for assessing the U.S. 
position internationally in nanotechnology. To date, the federal government does not collect data 
on nanotechnology-related revenues, trade, or employment, nor are comparable international 
government data available.  
Nevertheless, many nanotechnology experts assert that the United States, broadly speaking, is the 
global leader in nanotechnology. Some experts believe, however, that in contrast to many 
previous emerging technologies—such as semiconductors, satellites, software, and 
biotechnology—the U.S. lead is narrower, and the investment level, scientific and industrial 
infrastructure, technical capabilities, and science and engineering workforces of other nations are 
more substantial.  
Some organizations do occasionally produce estimates of global R&D and product revenues for 
nanotechnology. In the absence of formal data collection, these figures often depend on subjective 
estimates of nanotechnology’s contribution to a particular industry or product. While some 
products are defined by their nanotechnology properties (for example, nanoscale silver used for 
antibacterial purposes), many products incorporate nanotechnology as only a part of their 
functionality (for example, nanoscale gates in semiconductors) thus rendering an assessment of 
the value of nanotechnology in a particular product subjective (i.e., what percentage of 
semiconductor revenues should be attributed to nanotechnology). 
In 2014, Lux Research, Inc., an emerging technologies consulting firm, produced a report, 
Nanotechnology Update: Corporations Up Their Spending as Revenues for Nano-enabled 
Products Increases, that included an estimate of revenues from nanomaterials, nano-
intermediates, and nano-enabled products.28 The report, funded in part by the National Science 
Foundation and the National Nanotechnology Coordination Office, estimates that total global 
revenues from nano-enabled products reached $731 billion in 2012, up from $339 billion in 2010. 
Of the 2012 revenues, the United States accounted for $236 billion, or about one-third of total 
global sales, about the same as Europe ($235 billion) and about 10% higher than Asia ($214 
billion). Other countries—aggregated by Lux Research as “Rest of the World”—accounted for an 
estimated $47 billion. Subsequently, Lux Research projected global revenue from 
nanotechnology-enabled products would grow to nearly $3.7 billion in 2018.29 
An alternative mechanism for gauging a nation’s competitive position in emerging 
technologies—in the absence of periodic, comprehensive, and reliable economic output data (e.g., 
                                                 
28 Nano-intermediates include, for example, nano-based coatings, fabrics, memory and logic chips, contrast media, 
optical components, orthopedic materials, and superconducting wire that are incorporated into nano-enabled products, 
such as cars, clothing, aircraft, computers, consumer electronic devices, and pharmaceuticals. 
29 Patrick Marshall, “Nanotechnology: Will the Science of Atom-Size Objects Reshape the Economy?,” CQ 
Researcher, CQ Press, June 10, 2016. 
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revenues, market share, trade)—is the use of inputs (e.g., public and private research investments) 
and non-financial outputs (e.g., scientific papers, patents). By these measures (discussed below), 
the United States appears to lead the world, generally, in nanotechnology. However, R&D 
investments, scientific papers, and patents may not provide reliable indicators of the United 
States’ current or future competitive position. Scientific and technological leadership may not 
necessarily result in commercial leadership or national competitiveness for a variety of reasons: 
 Basic research in nanotechnology may not translate into viable commercial 
applications. 
 Basic research results are generally available to all competitors. 
 U.S.-based companies may conduct production and other work outside of the 
United States. 
 U.S.-educated foreign students may return home to conduct research and create 
new businesses. 
 U.S. companies with leading-edge nanotechnology capabilities and/or intellectual 
property may be acquired by foreign competitors. 
 U.S. policies or other factors may prohibit nanotechnology commercialization, 
make it unaffordable, or make it less attractive than foreign alternatives. 
 Aggregate national data may be misleading as countries may establish global 
leadership in niche areas of nanotechnology. 
With these caveats, the following section reviews input and non-economic output measures as 
indicators of the U.S. competitive position in nanotechnology. 
Global Funding 
The United States has led, and continues to lead, all nations in known public investments in 
nanotechnology R&D, though the estimated U.S. share of global public investments has fallen as 
other nations have established similar programs and increased funding. In its 2014 report, Lux 
Research estimated total (public and private) global nanotechnology funding for 2012 to be 
approximately $18.5 billion, of which the United States accounted for approximately $6.6 billion 
(36%). In 2010 corporate R&D accounted for a majority of global nanotechnology funding for 
the first time.30 Cientifica, a privately held nanotechnology business analysis and consulting firm, 
estimated global public investments in nanotechnology in 2010 to be approximately $10 billion 
per year, with cumulative global public investments through 2011 reaching approximately $67.5 
billion. Cientifica also concluded that the United States had fallen behind both Russia and China 
in nanotechnology R&D funding on a purchasing power parity (PPP) basis (which takes into 
account the price of goods and services in each nation), but still led the world in real dollar terms 
(adjusted on a currency exchange rate basis).31  
Private investments in nanotechnology R&D come from two primary sources, corporations and 
venture capital (VC) investors. According to Lux Research, between 2010 and 2012 corporate 
spending on nanotechnology R&D increased fastest in the United States (32%), followed by Asia 
                                                 
30 OECD /NNI International Symposium on Assessing the Economic Impact of Nanotechnology, Background Paper 2: 
Finance and Investor Models in Nanotechnology, Working Party on Nanotechnology, Organization for Economic 
Cooperation and Development, March 16, 2012, p. 4. 
31 Global Funding of Nanotechnologies and Its Impact, Cientifica, July 2011, available at http://cientifica.eu/blog/wp-
content/uploads/downloads/2011/07/Global-Nanotechnology-Funding-Report-2011.pdf. 
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(11%), and Europe (3%). All other nations, collectively, increased funding by 22%.32 Total global 
corporate nanotechnology R&D spending in 2012 was an estimated $9.4 billion (in PPP dollars), 
led by the United States ($4.1 billion), Japan ($2.3 billion), Germany ($707 million), China 
(approximately $400 million), and Korea ($474 million).33 
According to Lux Research, venture capital funding for nanotechnology fell 27% in 2012, from 
an estimated $793 million in 2011 to $580 million in 2012. The United States accounted for more 
than $400 million of VC funding, nearly 70% of total global VC funding, followed by the United 
Kingdom with more than $100 million in 2012.34 Lux Research previously reported that the 
amount of venture capital funding in Europe was one-fifth that of the North American level.35 
Scientific Papers 
The publication of peer-reviewed scientific papers is considered by some to be an indicator of a 
nation’s scientific leadership. A study by the National Bureau of Economic Research in 2005 
reported that the U.S. share of nanotechnology papers was a world-leading 24%, but that this 
represented a decline from approximately 40% in the early 1990s, concluding: 
Taken as a whole these data confirm that the strength and depth of the American science 
base points to the United States being the dominant player in nanotechnology for some 
time to come, while the United States also faces significant and increasing international 
competition.
36
 
Reflecting the same trend, the number of papers in the Science Citation Index (SCI)37 related to 
nanotechnology discoveries rose from 18,085 in 2000 to approximately 65,000 in 2008, a 
compound annual growth rate (CAGR) of 17.3%. The U.S. share of these papers grew at a 
somewhat slower pace (13.8% CAGR) from 5,342 in 2000 to approximately 15,000 in 2008, 
reducing the U.S. share from 29.5% in 2000 to approximately 23.1% in 2008.38 
In more recent year, the number of nanotechnology papers published by China and the European 
Union has exceeded that of the United States. (See Figure 3.) 
                                                 
32 Nanotechnology Update: Corporations Up Their Spending as Revenues for Nano-enabled Products Increases, Lux 
Research, Inc., February 2014. 
33 Ibid. 
34 Ibid. 
35 OECD /NNI International Symposium on Assessing the Economic Impact of Nanotechnology, Background Paper 2: 
Finance and Investor Models in Nanotechnology, Working Party on Nanotechnology, Organization for Economic 
Cooperation and Development, March 16, 2012, p. 4. 
36 Zucker, L.G. and M.R. Darby. “Socio-Economic Impact of Nanoscale Science: Initial Results and Nanobank,” 
National Bureau of Economic Research, March 2005. 
37 The Science Citation Index, a product of Thomson Reuters Corporation, provides bibliographic and citation 
information from more than 3,700 scientific and technical journals published around the world. 
38 Mihail C. Roco, “The long view of nanotechnology development: the National Nanotechnology Initiative at 10 
years,” Journal of Nanoparticle Research, February 2011, p. 429. Growth rates and U.S. percentages of total 
publications calculated by CRS. 
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Figure 3. Number of Published Nanotechnology Papers for Selected Countries 
2011-2013 
 
Source: Executive Office of the President, Office of Science and Technology Policy, Report to the President and 
Congress on the Fifth Assessment of the National Nanotechnology Initiative, October 2014, 
https://www.whitehouse.gov/sites/default/files/microsites/ostp/PCAST/pcast_fifth_nni_review_oct2014_final.pdf. 
Notes: EU-28 refers to the 28 nations of the European Union. 
One measure of the importance of a scientific paper is the number of times it is cited in other 
papers. An analysis by Evaluametrics, Ltd. reports that nanotechnology papers attributed to the 
United States are much more frequently cited than those attributed to China, the nations of the 
European Union and the rest of the world as a whole. This held true overall and separately in each 
of the four disciplines examined (biology, chemistry, engineering, and physics). The U.S. lead 
was particularly pronounced in biology. China fell below the world average number of citations 
in each discipline, as well as overall. The European Union performed near the world average in 
engineering and physics, and somewhat higher in chemistry. 
Patents 
Patent counts—assessments of how many patents are issued to individuals or institutions of a 
particular country—are frequently used to assess technological competitiveness. By this measure, 
the U.S. competitive position in nanotechnology appears to be strong. A 2007 U.S. Patent and 
Trademark Office analysis of patents in the United States and in other nations stated that U.S.-
origin inventors and assignees/owners have 
 the most nanotechnology-related U.S. patents by a wide margin; 
 the most nanotechnology-related patent publications globally, but by a narrower 
margin (followed closely by Japan); and 
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 the most nanotechnology-related inventions that have patent publications in three 
or more countries (31.7%), followed by Japan (26.9%), Germany (11.3%), Korea 
(6.6%), and France (3.6%).39 
Environmental, Health, and Safety Implications 
Some of the unique properties of nanoscale materials—for example their small size and high ratio 
of surface area to volume—have given rise to concerns about their potential implications for 
health, safety, and the environment. While nanoscale particles occur naturally and as incidental 
by-products of other human activities (e.g., soot), EHS concerns have been focused primarily on 
nanoscale materials that are intentionally engineered and produced.40 
Environmental, health, and safety (EHS) concerns include both direct consequences of 
nanotechnology for health, safety, and the environment, and how uncertainty about EHS 
implications and potential regulatory responses might affect U.S. competitiveness. One such 
effect might be the discouragement of investment in nanotechnology due to the possibility of 
regulations that might bar products from the market, impose high regulatory compliance costs, or 
result in product liability claims and clean-up costs. 
Much of the public dialogue about risks associated with nanotechnology has focused on carbon 
nanotubes (CNTs) and other fullerenes (molecules formed entirely of carbon atoms in the form of 
a hollow sphere, ellipsoid, or tube) since they are currently being manufactured and are among 
the most promising nanomaterials. These concerns have been amplified by some research on the 
effects of CNTs on animals, and on animal and human cells. For example, researchers have 
reported that carbon nanotubes inhaled by mice can cause lung tissue damage;41 that buckyballs 
(spherical fullerenes) caused brain damage in fish;42 and that buckyballs can accumulate within 
cells and potentially cause DNA damage.43 On the other hand, work at Rice University’s Center 
for Biological and Environmental Nanotechnology conducted in 2005 found cell toxicity of CNTs 
to be low and that toxicity can be reduced further through simple chemical changes to the CNT’s 
surface.44 
Among the potential EHS benefits of nanotechnology are applications that may reduce energy 
consumption, pollution, and greenhouse gas emissions; remediate environmental damage; cure, 
manage, or prevent deadly diseases; and offer new materials that protect against impacts, self-
repair to prevent catastrophic failure, or change in ways that provide protection and medical aid to 
soldiers on the battlefield. 
Potential EHS risks of nanoscale particles in humans and animals depend in part on their potential 
to accumulate, especially in vital organs such as the lungs and brain, that might harm or kill, and 
to diffuse in the environment and potentially harm ecosystems. For example, several products on 
                                                 
39 Eloshway, Charles. “Nanotechnology Related Issues at the U.S. Patent and Trademark Office,” Workshop on 
Intellectual Property Rights in Nanotechnology: Lessons from Experiences Worldwide, Brussels, Belgium, April 2007. 
40 Some naturally occurring nanoparticles cause adverse health effects. Studies on the effects of naturally occurring 
particles are numerous and inform R&D on engineered nanoparticles. 
41 Lam, C.; James, J.T.; McCluskey, R.; and Hunter, R. “Pulmonary toxicity of single-wall carbon nanotubes in mice 7 
and 90 days after intratracheal instillation,” Toxicological Sciences, September 2003. Vol 77. No. 1. pp 126-134. 
42 Oberdörster, Eva. “Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile 
Largemouth Bass,” Environmental Health Perspectives, July 2004. Vol. 112. No. 10. 
43 “Understanding Potential Toxic Effects of Carbon-Based Nanomaterials,” Nanotech News, National Cancer Institute 
Alliance for Nanotechnology in Cancer, July 10, 2006. 
44 “Modifications render carbon nanotubes nontoxic,” press release, Rice University, October 2005. 
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the market today contain nanoscale silver, an effective antibacterial agent. Some scientists have 
raised concerns that the dispersion of nanoscale silver in the environment could kill microbes that 
are vital to ecosystems. 
Like nanoscale silver, other nanoscale particles might produce both positive and negative effects. 
For example, some nanoscale particles have the potential to penetrate the blood-brain barrier, a 
structure that protects the brain from harmful substances in the blood. Currently, the barrier 
hinders the delivery of therapeutic agents to the brain.45 The characteristics of some nanoscale 
materials may allow pharmaceuticals to be developed to purposefully and beneficially cross the 
blood-brain barrier and deliver medicine directly to the brain to treat, for example, a brain tumor. 
Alternatively, other nanoscale particles might unintentionally pass through this barrier and harm 
humans and animals. 
There is widespread uncertainty about the potential EHS implications of nanotechnology. A 
survey of business leaders in the field of nanotechnology indicated that nearly two-thirds believe 
that “the risks to the public, the workforce, and the environment due to exposure to nano particles 
are ‘not known,’” and 97% believe that it is very or somewhat important for the government to 
address potential health effects and environmental risks that may be associated with 
nanotechnology.46 
Many stakeholders believe that concerns about potential detrimental effects of nanoscale 
materials and products on health, safety, and the environment—both real and perceived—must be 
addressed for a variety of reasons, including the following: 
 protecting and improving human health, safety, and the environment; 
 enabling accurate and efficient risk assessments, risk management, and cost-
benefit trade-offs; 
 creating a predictable, stable, and efficient regulatory environment that fosters 
investment in nanotechnology-related innovation; 
 ensuring public confidence in the safety of nanotechnology research, 
engineering, manufacturing, and use; 
 preventing the negative consequences of a problem in one application area of 
nanotechnology from harming the use of nanotechnology in other applications 
due to public fears, political interventions, or an overly broad regulatory 
response; and 
 ensuring that society can enjoy the widespread economic and societal benefits 
that nanotechnology may offer. 
Policy issues associated with EHS impacts of nanotechnology include the magnitude, timing, 
foci, and management of the federal investment in EHS research; the adequacy of the current 
regulatory structures to protect public health and the environment; and cooperation with other 
nations engaged in nanotechnology R&D to ensure all are doing so in a responsible manner. 
                                                 
45 “Blood-Brain Barrier Breached by New Therapeutic Strategy,” press release, National Institutes of Health, June 
2007. 
46 “Survey of U.S. Nanotechnology Executives,” Small Times Magazine and the Center for Economic and Civic 
Opinion at the University of Massachusetts-Lowell, Fall 2006. 
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Nanomanufacturing 
Securing the potential economic and societal benefits of nanotechnology requires the ability to 
translate knowledge of nanoscience into market-ready nanotechnology products. 
Nanomanufacturing is the bridge connecting nanoscience and nanotechnology products. Although 
some nanotechnology products have already entered the market, these materials and devices have 
tended to require only incremental changes in manufacturing processes. Generally, they are 
produced in a laboratory environment in limited quantities with a high degree of labor intensity, 
high variability, and high costs. To make their way into safe, reliable, effective, and affordable 
commercial-scale production in a factory environment may require the development of new and 
unique technologies, tools, instruments, measurement science, and standards for 
nanomanufacturing. 
Several federal agencies support nanomanufacturing R&D focusing on the development of 
scalable, reliable, cost-effective manufacturing of nanoscale materials, structures, devices, and 
systems. In its FY2014 budget supplement, the NNI reported nanomanufacturing R&D funding of 
eight agencies totaling $93.9 million in FY2013, and proposed funding of $100.3 million for 
FY2014. In its FY2015 budget supplement, the NNI changed its data collection and reporting 
taxonomy, eliminating the Nanomanufacturing program component area (PCA).47 Under the new 
PCA taxonomy, nanomanufacturing R&D funding is included in the Nanotechnology Signature 
Initiatives48 PCA under the subcategory “Sustainable Nanomanufacturing: Creating the Industries 
of the Futures” and may also be included as part of the figures reported for other PCAs, the 
Foundational Research PCA and Nanotechnology-Enabled Applications, Devices, and Systems 
PCA in particular. Since the other PCAs are not further parsed, it is not possible to identify total 
funding for nanomanufacturing R&D. The President’s FY2016 budget proposes $42.6 million for 
the Sustainable Nanomanufacturing initiative in FY2016, with NSF ($26.4 million, 62% of total 
proposed funding), NIST ($6.8 million, 16%), and DOE ($3.0 million, 7%) accounting for the 
largest amount of funds.  
In addition, some agencies seek to advance nanomanufacturing through non-R&D activities. For 
example, the National Institute for Occupational Safety and Health is seeking to stave off 
potential nanomanufacturing EHS problems by developing and disseminating case studies that 
demonstrate the utility of applying “Prevention through Design” principles to nanomanufacturing. 
Public Attitudes and Understanding 
What the American people know about nanotechnology and their attitudes toward it may affect 
the environment for research and development (especially support for public R&D funding), 
regulation, market acceptance of products incorporating nanotechnology, and, perhaps, the ability 
of nanotechnology to weather a negative event such as an industrial accident. 
                                                 
47 The 21st Century Nanotechnology Research and Development Act directed the NNI to develop and report 
nanotechnology R&D funding in finer detail using categories called “Program Component Areas,” or PCAs. 
48 NNI Signature Initiatives are areas of particular focus—solar energy, next-generation electronics, and sustainable 
manufacturing—in which participating agencies have identified key opportunities and plan more intensive 
programmatic collaboration. There are currently five Signature Initiatives: Nanotechnology for Solar Energy Collection 
and Conversion; Sustainable Nanomanufacturing—Creating the Industries of the Future; Nanoelectronics for 2020 and 
Beyond; Nanotechnology Knowledge Infrastructure (NKI): Enabling National Leadership in Sustainable Design; and 
Nanotechnology for Sensors and Sensors for Nanotechnology—Improving and Protecting Health, Safety, and the 
Environment. 
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In 2009, the Woodrow Wilson International Center for Scholars Project on Emerging 
Nanotechnologies (PEN) reported results of a nationwide poll of adults that found 68% had heard 
little (31%) or nothing at all (37%) about nanotechnology, while only 31% said that they had 
heard a lot (9%) or some (22%).49 In a 2007 poll, more than half of those surveyed felt they could 
not assess the relative value of nanotechnology’s risks and benefits. Among those most likely to 
believe that the benefits outweigh the risks were those earning more than $75,000 per year, men, 
people who had previously heard “some” or “a lot” about nanotechnology, and those between the 
ages of 35 and 64. Conversely, those most likely to believe that the risks of nanotechnology 
outweigh the benefits included people earning $30,000 or less; those with a high school diploma 
or less; women; racial and ethnic minorities; and those between the ages of 18 and 34 or over age 
65.50 The 2007 PEN survey found a strong positive correlation between nanotechnology 
familiarity/awareness and perceptions that benefits will outweigh risks. However, the survey data 
also indicate that communicating with the public about nanotechnology in the absence of clear, 
definitive answers to EHS questions could create a higher level of uncertainty, discomfort, and 
opposition. 
Congress expressed its belief in the importance of public engagement in the 21st Century 
Nanotechnology Research and Development Act of 2003 (15 U.S.C. §§7501-7502.). The act calls 
for public input and outreach to be integrated into the NNI’s efforts. The NNI has sought to foster 
public understanding through a variety of mechanisms, including written products, speaking 
engagements, a web-based information portal (nano.gov), informal education, and efforts to 
establish dialogues with stakeholders and the general public. The NSET subcommittee has also 
established a Nanotechnology Public Engagement and Communications working group to 
develop approaches by which the NNI can communicate more effectively with the public. 
Concluding Observations 
The federal government has made sustained investments in nanotechnology under the NNI since 
FY2001. While numerous nanotechnology applications have been incorporated in commercial 
products, they have generally offered incremental improvements in product performance. 
Proponents assert that nanotechnology has the potential to bring revolutionary products to market, 
reshaping existing industries and creating new ones. These products may bring significant 
economic and social benefits to the United States and to the world; however, substantial research, 
development, and innovation-related hurdles remain before these benefits might be realized.  
Congress may play an active role in addressing some or all of these hurdles. The issues Congress 
may opt to consider include budget authorization levels for the covered agencies; R&D funding 
levels, priorities, and balance across the program component areas; administration and 
management of the NNI; translation of research results and early-stage technology into 
commercially viable applications; environmental, health, and safety issues; ethical, legal, and 
societal implications; education and training for the nanotechnology workforce; metrology, 
standards, and nomenclature; public understanding; and international dimensions.  
                                                 
49 Peter D. Hart Research Associates, Inc., “Nanotechnology, Synthetic Biology, and Public Opinion: A Report of 
Findings Based on a National Survey Among Adults,” conducted on behalf of Project on Emerging Nanotechnologies, 
Woodrow Wilson International Center for Scholars, September 22, 2009, http://www.nanotechproject.org/process/
assets/files/8286/nano_synbio.pdf. 
50 Peter D. Hart Research Associates, Inc., “Awareness of and Attitudes Toward Nanotechnology and Federal 
Regulatory Agencies: A Report of Findings,” conducted on behalf of Project on Emerging Nanotechnologies, 
Woodrow Wilson International Center for Scholars, September 2007. 
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Appendix. Department/Agency Members of the 
NSET Subcommittee 
As of April 2014, the NSET subcommittee included the following member departments and 
agencies: 
Consumer Product Safety Commission†* 
Department of Agriculture 
Agricultural Research Service† 
Forest Service† 
National Institute of Food and Agriculture† 
Department of Commerce 
Bureau of Industry and Security 
Economic Development Administration 
National Institute of Standards and Technology† 
U.S. Patent and Trademark Office 
Department of Defense† 
Department of Education 
Department of Energy† 
Department of Health and Human Services 
Agency for Toxic Substances and Disease Registry 
Food and Drug Administration† 
National Institute for Occupational Safety and Health† 
National Institutes of Health† 
Department of Homeland Security† 
Department of the Interior 
Department of Justice 
Department of Labor 
Department of State 
Department of Transportation† 
Department of Treasury 
Environmental Protection Agency† 
Intelligence Community 
National Aeronautics and Space Administration† 
National Science Foundation† 
Nuclear Regulatory Commission* 
U.S. International Trade Commission* 
 
 
†  Indicates a federal department, independent agency, or commission with a budget dedicated 
to nanotechnology research and development. 
 
*  Indicates an independent commission that is represented on NSET but is non-voting. 
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